Stocks Health care PAVM
NASDAQ · Health carePAVmed Inc. (PAVM)
PAVmed Inc. brought in $112K of revenue over the twelve months to June 30, 2026, down 88.8% from a year earlier. It posted a net loss of $12.1M. In fiscal 2025 capital spending exceeded operating cash flow by $5.2M. At June 30, 2026 it held $3.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What PAVmed Inc. does
PAVmed Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PAVM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $71K | $401K | -$5.63 | -$5.2M |
| 2024 | $3M | $39.8M | $14.90 | -$33.6M |
| 2023 | $2.5M | -$64.2M | -$272.97 | -$52.3M |
| 2022 | $377K | -$89M | -$447.89 | -$72.5M |
| 2021 | $500K | -$50.3M | -$19.37 | -$42.1M |
| 2020 | n/a | -$34.3M | -$21.46 | -$22M |
Latest SEC filings
What PAVmed Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 10, 2026
- September 10, 2026
- August 14, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- July 30, 2026
- June 24, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 15, 2026
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about PAVM
What does PAVmed Inc. do?
PAVmed Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PAVM.
Is PAVmed Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $12.1M on revenue of $112K.
How much revenue does PAVmed Inc. make?
Over the twelve months to June 30, 2026 PAVmed Inc. reported revenue of $112K. That is 88.8% less than a year earlier.
When did PAVmed Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 10, 2026.
Similar companies
Follow PAVM
Get an email when PAVmed Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PAVM: get an email when it filesWhere the numbers come from
Financial figures are the values PAVmed Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.